PM360 2021 Innovative Product Evidence-based Physician Engagement Solution from OptimizeRx

DECEMBER 13, 2021

Evidence-based Physician Engagement Solution

For years, the life sciences industry has been executing on real-world data (RWD) insights months after the data is collected—in a retrospective, rather than prospective needs-based manner. But OptimizeRx’s Evidence-based Physician Engagement is a patent-pending solution that uses its AI-driven Therapy Initiation and Persistence Platform to deliver tailored engagement leveraging RWD insights in real-time.

Using predictive analytics via machine learning methods applied to RWD, the Therapy Initiation and Persistence Platform can assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. This real-world evidence (RWE) translates into better support for providers as they look to make the best treatment decisions for their patients, especially for those with complex dosing requirements or chronic disease indications.

Read the full article on PM360 Online Magazine
Discover how our provider engagement solutions can help your brand

get in touch with us

Discover all our point-of-care communication platform can do for your brand

SEE OUR PLATFORM CAPABILITIES